HCSGD entry for TBK1
1. General information
Official gene symbol | TBK1 |
---|---|
Entrez ID | 29110 |
Gene full name | TANK-binding kinase 1 |
Other gene symbols | NAK T2K |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0002218 | Activation of innate immune response | IEA | biological_process |
GO:0002224 | Toll-like receptor signaling pathway | TAS | biological_process |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | TAS | biological_process |
GO:0003676 | Nucleic acid binding | IEA | molecular_function |
GO:0004672 | Protein kinase activity | IEA TAS | molecular_function |
GO:0004674 | Protein serine/threonine kinase activity | TAS | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0005737 | Cytoplasm | IDA | cellular_component |
GO:0005829 | Cytosol | TAS | cellular_component |
GO:0006954 | Inflammatory response | TAS | biological_process |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | TAS | biological_process |
GO:0009615 | Response to virus | TAS | biological_process |
GO:0010008 | Endosome membrane | TAS | cellular_component |
GO:0010629 | Negative regulation of gene expression | IEA | biological_process |
GO:0016032 | Viral process | IEA | biological_process |
GO:0032480 | Negative regulation of type I interferon production | TAS | biological_process |
GO:0032481 | Positive regulation of type I interferon production | TAS | biological_process |
GO:0032606 | Type I interferon production | TAS | biological_process |
GO:0032727 | Positive regulation of interferon-alpha production | IDA | biological_process |
GO:0032728 | Positive regulation of interferon-beta production | IDA | biological_process |
GO:0033138 | Positive regulation of peptidyl-serine phosphorylation | NAS | biological_process |
GO:0034138 | Toll-like receptor 3 signaling pathway | TAS | biological_process |
GO:0034142 | Toll-like receptor 4 signaling pathway | TAS | biological_process |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | TAS | biological_process |
GO:0043123 | Positive regulation of I-kappaB kinase/NF-kappaB signaling | IEP | biological_process |
GO:0045087 | Innate immune response | TAS | biological_process |
GO:0045359 | Positive regulation of interferon-beta biosynthetic process | IEA | biological_process |
GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | IDA | biological_process |
GO:0050830 | Defense response to Gram-positive bacterium | IEA | biological_process |
GO:0051219 | Phosphoprotein binding | IPI | molecular_function |
GO:0051607 | Defense response to virus | IEA | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.0973055697 | 0.7112053379 | 0.6525496179 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.3599894698 |
GSE13712_SHEAR | Up | 0.1086251465 |
GSE13712_STATIC | Up | 0.0827033125 |
GSE19018 | Up | 0.0005729742 |
GSE19899_A1 | Up | 0.0294937664 |
GSE19899_A2 | Up | 0.2976605407 |
PubMed_21979375_A1 | Down | -0.0410032994 |
PubMed_21979375_A2 | Up | 0.4147928180 |
GSE35957 | Up | 0.1364149649 |
GSE36640 | Up | 0.4513268075 |
GSE54402 | Up | 0.5444033087 |
GSE9593 | Up | 0.0490725161 |
GSE43922 | Up | 0.1056578458 |
GSE24585 | Up | 0.0586997031 |
GSE37065 | Up | 0.5290706710 |
GSE28863_A1 | Down | -0.0526818579 |
GSE28863_A2 | Up | 0.0616399463 |
GSE28863_A3 | Down | -0.7589229787 |
GSE28863_A4 | Up | 0.2082560398 |
GSE48662 | Down | -0.6298367675 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Not regulated by drugs
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-221-3p | MIMAT0000278 | MIRT003360 | Reporter assay;Western blot;Microarray | Functional MTI | 20018759 |
hsa-miR-200c-3p | MIMAT0000617 | MIRT006971 | Luciferase reporter assay//Western blot | Functional MTI | 22991189 |
Entries Per Page
Displaying Page of
- mirRecord
MicroRNA name | mirBase ID | Target site number | MiRNA mature ID | Test method inter | MiRNA regulation site | Reporter target site | Pubmed ID |
---|---|---|---|---|---|---|---|
hsa-miR-221-3p | MIMAT0000278 | NA | hsa-miR-221 | {Western blot} | {overexpression by miRNA precursor transfection} | 20018759 |
Entries Per Page
Displaying Page of
6. Text-mining results about the gene
Gene occurances in abstracts of cellular senescence-associated articles: 2 abstracts the gene occurs.
PubMed ID of the article | Sentenece the gene occurs |
---|---|
25594009 | Targeting HER2(+) breast cancer: the TBK1/IKKepsilon axis |
25594009 | We performed a lenti-viral shRNA kinome screen on non-adherent mouse Her2/Neu tumorspheres and identified TBK1, a non-canonical IkappaB kinase (IKK), as the most potent target [1] |
25594009 | TBK1 knock-down, or treatment with TBK1-II, a drug that efficiently inhibits TBK1 and its close relative IKKepsilon (IKBKE), suppressed growth of human HER2(+) BC cells and induced cellular senescence |
25594009 | Thus, TBK1/IKKepsilon inhibitors may improve treatment of HER2(+) BC in cooperation with anti-HER2 therapy |
24487029 | We identified kinases such as the mitogen-activated protein kinase and the TGFbetaR protein family, previously implicated in HER2(+) breast cancer, as well as autophagy factor ATG1/ULK1 and the noncanonical IkappaB kinase (IKK), TANK-binding kinase 1 (TBK1), which have not been previously linked to HER2(+) breast cancer |
24487029 | Knockdown of TBK1 or pharmacologic inhibition of TBK1 and the related protein, IKKepsilon, suppressed growth of both mouse and human HER2(+) breast cancer cells |
24487029 | TBK1/IKKepsilon inhibition promoted cellular senescence by suppressing p65-NF-kappaB and inducing p16(Ink4a) |
24487029 | In addition, TBK1/IKKepsilon inhibition cooperated with lapatinib, a HER2/EGFR1-targeted drug, to accelerate apoptosis and kill HER2(+) breast cancer cells both in culture and in xenografts |
Entries Per Page
Displaying Page of